Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-15 Sale |
2021-03-16 7:45 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
22,912 | $6.9151 | $158,440 | 122,746 (Direct) |
View |
| 2020-12-16 Purchase |
2020-12-17 2:43 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Artal International S.C.A. Minne Pascal Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner |
10,937,500 | $3.2 | $35,000,000 | 71,178,364 (Indirect) |
View |
| 2020-12-16 Purchase |
2020-12-17 2:39 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner |
10,937,500 | $3.2 | $35,000,000 | 71,178,364 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-30 Option Award |
2021-05-03 5:03 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:02 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:02 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:51 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:50 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
10,638 | $0 | 151,397 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:49 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
10,638 | $0 | 27,720 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:47 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
10,638 | $0 | 4,648,735 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:46 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
10,638 | $0 | 66,291 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 7:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
12,000 | $3.31 | 122,746 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 7:45 pm |
N/A 2030-02-06 |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
12,000 | $0 | 122,746 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:01 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L EVP, Corp Adm Affairs and CFO |
26,584 | $7.19 | 243,243 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:01 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L EVP, Corp Adm Affairs and CFO |
68,109 | $0 | 243,243 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D |
16,560 | $7.19 | 204,771 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D |
68,007 | $0 | 204,771 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
10,765 | $7.19 | 119,508 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
28,316 | $0 | 119,508 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:59 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
20,413 | $7.19 | 209,668 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:59 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
56,468 | $0 | 209,668 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T VP, General Counsel & Secr. |
14,860 | $7.19 | 126,797 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T VP, General Counsel & Secr. |
38,765 | $0 | 126,797 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
55,038 | $7.19 | 685,353 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
192,885 | $0 | 685,353 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:43 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L EVP, Corp Adm Affairs and CFO |
134,130 | $0 | 134,130 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:41 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D |
128,410 | $0 | 128,410 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:16 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
40,570 | $0 | 40,570 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:14 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
107,710 | $0 | 107,710 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:13 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T VP, General Counsel & Secr. |
105,010 | $0 | 105,010 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:10 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-01-21 6:04 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Wittouck Amaury Director 10% Owner |
0 | $0 | 71,178,364 (Indirect) |
View |
Ownership |
2021-01-11 5:38 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus Partners LLC Director 10% Owner |
0 | $0 | 4,321,214 (Direct) |
View |
| 2020-12-31 Other |
2021-01-05 9:21 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus C.V. Director 10% Owner |
4,321,214 | $0 | 4,321,214 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:49 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
28,753 | $0 | 45,121 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:49 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
3,466 | $0 | 45,121 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:48 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
28,753 | $0 | 169,512 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
3,466 | $0 | 169,512 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:48 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
28,753 | $0 | 45,121 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
3,466 | $0 | 45,121 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:47 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
28,753 | $0 | 45,835 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:47 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
3,466 | $0 | 45,835 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:46 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
28,753 | $0 | 45,121 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:46 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
3,466 | $0 | 45,121 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:45 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
28,753 | $0 | 4,666,850 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
3,466 | $0 | 4,666,850 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:44 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
28,753 | $0 | 84,406 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:44 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
3,466 | $0 | 84,406 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:43 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
28,753 | $0 | 45,121 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:43 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
3,466 | $0 | 45,121 (Direct) |
View |